Alzheimer's disease: transgenic models to test new chemicals and pharmaceuticals.
Curr Opin Biotechnol
; 3(6): 683-6, 1992 Dec.
Article
en En
| MEDLINE
| ID: mdl-1369125
ABSTRACT
Alzheimer's disease is the most common form of senile dementia and is predicted to become even more prevalent as the proportion of elderly in the population increases over the next few decades. As yet, there are no effective treatments for the disorder. A major limitation to identifying new drugs and therapeutic targets for Alzheimer's disease has been the absence of an animal model displaying typical Alzheimer's pathology. Transgenic technology is now providing a powerful new approach for the development of animal models of Alzheimer's disease.
Search on Google
Banco de datos:
MEDLINE
Asunto principal:
Animales Modificados Genéticamente
/
Enfermedad de Alzheimer
Tipo de estudio:
Prognostic_studies
Límite:
Animals
/
Humans
Idioma:
En
Año:
1992
Tipo del documento:
Article